Fluidigm has appointed AH diagnostics as its exclusive distributor in Scandinavia (Sweden, Norway, Finland, Denmark, Iceland), effective February 1, 2012. AH diagnostics will offer Fluidigm's complete portfolio of BioMark HD, EP1, and Access Array Systems, the complete line up of Dynamic Array, Digital Array and Access Array IFCs for real-time PCR, digital PCR, single-cell gene expression, sample preparation for next-generation sequencing, and SNP genotyping; plus Fluidigm's new DELTAgene and SNPtype assays.
AH diagnostics was established to supply products and services to life science and diagnostic companies in the pharmaceutical, biotech, hospital and academic research fields. The company has operations in Denmark, Sweden, Norway and Finland. AH diagnostics has built its reputation across Scandinavia as a distribution leader in the life science field, representing leading global manufacturers, such as Fluidigm, providing next-generation tools, technologies, training, applications support, instrument installation, validation, and maintenance support to life science researchers.
"Our goal is to be the supplier of choice for high quality and innovative products, equipment and related support services in Scandinavia within the biotechnology/life science area in selected segments," said Niels Rüdiger, Chief Executive Officer, AH diagnostics. "We are excited to add Fluidigm's innovative microfluidic products that provide unique solutions for many of the critical research challenges facing our scientists."
"Fluidigm is committed to continuing to bring the accuracy and efficiency benefits of integrated fluidic circuit technology to life science researchers in Scandinavia," said Dominique Remy-Renou, Vice President of European Commercial Operations, Fluidigm Europe BV. "AH diagnostics has built a strong reputation across Scandinavia for addressing the needs of the life science research community. We look forward to helping them bring the tools needed to solve some of today's most complex genetic questions in biology all the way down to the single cell."
Source: Fluidigm Corp.